The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Carbonic anhydrase inhibitors and their therapeutic potential
Abstract
Carbonic anhydrases (CAs, EC 4.2.1.1) are wide-spread zinc enzymes, present in archaeo- and eubacteria, algae, green plants and animals. Within these organisms CAs are encoded by three distinct, evolutionarily unrelated gene families: the α-CA, the β-CA and the γ-CA families, respectively. These enzymes are very efficient catalysts for the reversible hydration of CO2 to bicarbonate; the α-CAs possess high versatility, being able to catalyse other hydrolytic processes. It is not known whether other reactions catalysed by CAs (than the hydration of CO2/dehydration of HCO-) may have physiological relevance in systems where these enzymes are present. CAs are inhibited primarily by two main classes of compounds: the metal complexing inorganic anions (e.g., cyanide, cyanate, thiocyanate, azide, hydrogensulphide etc.) and the unsubstituted sulphonamides possessing the general formula RSO2NH2 (R = aryl; hetaryl; perhaloalkyl). The first type of inhibitor was important for understanding in detail the catalytic and inhibitory mechanisms, whereas the second led to the development of several classes of pharmacological agents. Inhibitors of both types directly bind to the metal ion within the enzyme active site, either by substituting the zinc-bound H-, or adding to the co-ordination sphere, leading thus to pentaco-ordinated Zn(II). Sulphonamide CA inhibitors (CAIs) are useful as diuretics, or in the treatment and prevention of a variety of diseases such as glaucoma, epilepsy, congestive heart failure, mountain sickness, gastric and duodenal ulcers, neurological disorders and osteoporosis among others, as well as diagnostic tools. Their applications are due to the wide distribution of the different α-CA isozymes (14 are presently known) in higher vertebrates, where they play important physiological functions related to respiration and transport of CO2/HCO3 between metabolising tissues and the lungs, pH and CO2 homeostasis, electrolyte secretion in a variety of tissues/organs, and biosynthetic reactions, such as gluconeogenesis and ureagenesis, among others. CA activators have recently been described and their mechanism of action at molecular level elucidated. Such agents might be useful for developing therapies for the CA deficiency syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · Applied Ergonomics · doi:10.1016/0003-6870(92)90338-v · Cited by 7,112
Carbonic anhydrase: chemistry, physiology, and inhibition
Maren, T. H. (1967) · Physiological Reviews · doi:10.1152/physrev.1967.47.4.595 · Cited by 1,889
HUMAN CARBONIC ANHYDRASES AND CARBONIC ANHYDRASE DEFICIENCIES
Sly, W. S., & Hu, P. Y. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.002111 · Cited by 830
Hewett-Emmett, D., & Tashian, R. E. (1996) · Molecular Phylogenetics and Evolution · doi:10.1006/mpev.1996.0006 · Cited by 613
Carbonic anhydrase is an ancient enzyme widespread in prokaryotes
Smith, K. S., Jakubzick, C., Whittam, T. S., & Ferry, J. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15184 · Cited by 427
Türeci, Ö., Sahin, U., Vollmar, E., Siemer, S., Göttert, E., Seitz, G., Parkkila, A.-K., Shah, G. N., Grubb, J. H., Pfreundschuh, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7608 · Cited by 360
Pastorekova, S., Parkkila, S., Parkkila, A., Opavsky, R., Zelnik, V, Saarnio, J., & Pastorek, J. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024293 · Cited by 351
Treatment of Chronic Macular Edema With Acetazolamide
Cox, S. N., Hay, E., & Bird, A. C. (1988) · Archives of Ophthalmology · doi:10.1001/archopht.1988.01060140350030 · Cited by 320
Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro
Parkkila, S., Rajaniemi, H., Parkkila, A.-K., Kivelä, J., Waheed, A., Pastoreková, S., Pastorek, J., & Sly, W. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040554897 · Cited by 278
Carbonic anhydrase inhibitors: Sulfonamides as antitumor agents?
Supuran, C. T., Briganti, F., Tilli, S., Chegwidden, W. R., & Scozzafava, A. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00288-1 · Cited by 277
Self-citation
Cited by
Supuran, C. T., Scozzafava, A., & Casini, A. (2003) · Medicinal Research Reviews · doi:10.1002/med.10025 · Cited by 1,449
Self-citationAlterio, V., Di Fiore, A., D’Ambrosio, K., Supuran, C. T., & De Simone, G. (2012) · Chemical Reviews · doi:10.1021/cr200176r · Cited by 1,238
Self-citationPastorekova, S., Parkkila, S., Pastorek, J., & Supuran, C. T. (2004) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360410001689540 · Cited by 662
Self-citationZhao, C., Rakesh, K. P., Ravidar, L., Fang, W.-Y., & Qin, H.-L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.017 · Cited by 651
Carbonic anhydrases as targets for medicinal chemistry
Supuran, C. T., & Scozzafava, A. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.04.020 · Cited by 580
Self-citationWeber, A., Casini, A., Heine, A., Kuhn, D., Supuran, C. T., Scozzafava, A., & Klebe, G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030912m · Cited by 454
Self-citationCarbonic anhydrase inhibitors: Sulfonamides as antitumor agents?
Supuran, C. T., Briganti, F., Tilli, S., Chegwidden, W. R., & Scozzafava, A. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00288-1 · Cited by 277
Self-citationAntiobesity carbonic anhydrase inhibitors: a literature and patent review
Scozzafava, A., Supuran, C. T., & Carta, F. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.790957 · Cited by 273
Self-citationSulfonimidamides in Medicinal and Agricultural Chemistry
Chinthakindi, P. K., Naicker, T., Thota, N., Govender, T., Kruger, H. G., & Arvidsson, P. I. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610456 · Cited by 271
Abbate, F., Casini, A., Owa, T., Scozzafava, A., & Supuran, C. T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.062 · Cited by 262
Self-citationMishra, C. B., Tiwari, M., & Supuran, C. T. (2020) · Medicinal Research Reviews · doi:10.1002/med.21713 · Cited by 260
Self-citationApplications of carbonic anhydrase inhibitors and activators in therapy
Supuran, C. T., & Scozzafava, A. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.2.217 · Cited by 258
Self-citationThe Design of Inhibitors for Medicinally Relevant Metalloproteins
Jacobsen, F. E., Lewis, J. A., & Cohen, S. M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600204 · Cited by 132
Patel, T. N., Park, A. A., & Banta, S. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24863 · Cited by 38
Metadata
- Authors
- Supuran, C. T., & Scozzafava, A.
- Venue
- Expert Opinion on Therapeutic Patents
- Publisher
- Informa Healthcare
- Published
- 2000-05
- Volume
- 10
- Issue
- 5
- Pages
- 575-600
- ISSN
- 1354-3776 (ISSN-L)
- 1744-7674
- OpenAlex
- W2107966379
- Cited by
- 549
- References
- 55
- FWCI
- 7.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.